Imperial Pacific International (CNMI) LLC argues that the federal court should deny creditor Joshua Gray’s requests for sanctions (including contempt) against the casino investor and its director ...
Mexico central bank Deputy Governor Irene Espinosa said it’s too soon to talk about a prolonged easing cycle, less than a month since the central bank cut interest rates for the first time since ...
Michelle Heyman will spend the next six weeks training with a men’s team as she ... 62 minutes in last week’s 2-0 friendly win over Mexico – only her third cap since being recalled from ...
The code provides a set of tools that can be used by Eskom's system operator (which manages the grid) and electricity distributors (both municipal and from Eskom) when implementing load shedding - up ...
A Broadway legend’s longtime rural retreat has just sold for its full $3.25 million asking price. Less than six months after hitting the market for the first time in more than 39 years ...
I'm all in on the negative. No one's been harder on Trump than me. I get it, and I'm bored with it. There's a different way to do this, I think." "So what is it?" Couric asked. "Not to defend ...
In late February, news broke that the USA men's basketball program received a commitment from Jrue Holiday to suit up this summer in Paris. There, he'll join Boston Celtics teammate Jayson Tatum ...
McDonald’s is adding a new sandwich to its menus beginning on April 22, but it will only be available for a limited time, Parade reported. The Bacon Cajun Ranch McCrispy is an updated version of ...
Durant, 35, could have the chance to make history. He's one of two men's basketball players with three gold medals (tied with Carmelo Anthony), so a fourth in 2024 would make him the winningest ...
It's been a joy making the show with you. To writer and director and my friend Kip Williams, thank you for your trust, your ambition, and your brain." The Picture of Dorian Gray, which opened in ...
Imaginechina Limited, via Alamy Lawmakers raising national security concerns and seeking to disconnect a major Chinese firm from U.S. pharmaceutical interests have rattled the biotech industry.